DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,104,195 | +1.3% | 4,451 | -2.0% | 0.21% | +18.2% |
| Q2 2023 | $1,089,505 | +5.3% | 4,540 | +10.6% | 0.18% | -3.2% |
| Q1 2023 | $1,034,517 | -11.6% | 4,105 | -6.9% | 0.19% | -11.0% |
| Q4 2022 | $1,170,648 | +9.1% | 4,411 | +6.1% | 0.21% | -6.7% |
| Q3 2022 | $1,073,000 | 0.0% | 4,156 | -1.8% | 0.22% | +1.8% |
| Q2 2022 | $1,073,000 | -13.5% | 4,231 | 0.0% | 0.22% | +3.8% |
| Q1 2022 | $1,241,000 | -14.4% | 4,231 | -4.0% | 0.21% | -16.5% |
| Q4 2021 | $1,450,000 | +39.4% | 4,408 | +29.1% | 0.26% | +52.7% |
| Q3 2021 | $1,040,000 | +1.7% | 3,415 | -10.4% | 0.17% | +3.1% |
| Q2 2021 | $1,023,000 | +8.9% | 3,812 | +4.7% | 0.16% | -1.8% |
| Q1 2021 | $939,000 | +15.5% | 3,641 | -0.5% | 0.16% | +31.0% |
| Q4 2020 | $813,000 | +2.8% | 3,661 | -0.3% | 0.13% | -17.6% |
| Q3 2020 | $791,000 | +18.2% | 3,673 | -3.0% | 0.15% | +11.7% |
| Q2 2020 | $669,000 | +21.2% | 3,786 | -5.1% | 0.14% | -2.1% |
| Q1 2020 | $552,000 | -13.9% | 3,988 | -4.6% | 0.14% | +1.4% |
| Q4 2019 | $641,000 | +3.9% | 4,179 | -2.1% | 0.14% | +5.3% |
| Q3 2019 | $617,000 | +4.9% | 4,270 | +3.7% | 0.13% | +5.6% |
| Q2 2019 | $588,000 | +9.5% | 4,116 | +1.1% | 0.12% | -12.7% |
| Q1 2019 | $537,000 | +39.1% | 4,070 | +8.8% | 0.14% | +27.9% |
| Q4 2018 | $386,000 | 0.0% | 3,741 | +5.4% | 0.11% | +16.8% |
| Q3 2018 | $386,000 | +1.3% | 3,549 | -8.1% | 0.10% | -7.8% |
| Q2 2018 | $381,000 | +0.8% | 3,863 | 0.0% | 0.10% | -1.0% |
| Q1 2018 | $378,000 | +1.6% | 3,863 | -3.7% | 0.10% | +7.2% |
| Q4 2017 | $372,000 | -26.2% | 4,013 | -31.7% | 0.10% | -29.2% |
| Q3 2017 | $504,000 | +0.6% | 5,872 | -1.2% | 0.14% | -3.5% |
| Q2 2017 | $501,000 | -3.5% | 5,941 | -2.1% | 0.14% | -5.3% |
| Q1 2017 | $519,000 | +33.8% | 6,066 | +21.8% | 0.15% | +23.0% |
| Q4 2016 | $388,000 | +21.6% | 4,981 | +22.6% | 0.12% | +13.0% |
| Q3 2016 | $319,000 | +17.7% | 4,064 | +51.4% | 0.11% | +13.7% |
| Q2 2016 | $271,000 | +29.7% | 2,685 | +21.8% | 0.10% | +3.3% |
| Q1 2016 | $209,000 | -16.4% | 2,205 | -18.0% | 0.09% | -16.4% |
| Q4 2015 | $250,000 | +323.7% | 2,688 | +290.1% | 0.11% | +254.8% |
| Q3 2015 | $59,000 | -6.3% | 689 | -5.9% | 0.03% | -8.8% |
| Q2 2015 | $63,000 | +1.6% | 732 | 0.0% | 0.03% | +6.2% |
| Q1 2015 | $62,000 | – | 732 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |